Eve Health Group Ltd
EVE Health Group Limited is an Australia-based vertically integrated producer of branded nutrition, health and wellness products.
The business
EVE Health Group Limited is an Australia-based vertically integrated producer of branded nutrition, health and wellness products. The Company’s Meluka business provides branded wellness consumer products. Its Meluka business is focused on supporting sales of its digestive health products, in particular the P3 Gut Builder. It provides probiotic supplement powder system for improved digestive health. The functional gut nutrition solution is in the form of a three-step supplement powder system, each of which contain pre, pro and postbiotics as well as selected functional superfood ingredients in an easy to consume and versatile offering. The Company also offers honey and essential oil products. Its honey products include organic raw honey and raw honey probiotic concentrate. The Company has global reach and application to various markets across Australia and New Zealand, Asia Pacific and North America.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
EVE Health Secures $1.1m Funding to Propel Dyspro and Libbo Product Launches
EVE Health Group (ASX: EVE) has received stong support from sophisticated and professional investors for a capital raising aimed at accelerating the commercial rollout of its lead pharmaceutical products Dyspro and Libbo. When the placement attracted bids in excess of the $1 million EVE initially sought, the company increased the offer to $1.1m, the maximum capacity […]
EVE Health Group Confirms First Australian Prescriptions of Dyspro, Launches Support Platform
EVE Health Group (ASX: EVE) has prescribed its Dyspro cannabinoid-based gummy for the treatment of dysmenorrhoea and endometriosis to Australian patients for the first time. EVE issued the drug under the Therapeutic Goods Administration’s Special Access Scheme, marking the company’s transition from production and distribution to real-world patient access. The milestone follows the company’s successful completion […]
Why Investors Can’t Miss Spark Plus Australian Equities Day 2025
Discover Australia’s Next Wave of Growth The Spark Plus Australian Equities Day 2025 is more than just another investor showcase—it’s your gateway to the next generation of ASX growth stories. Across 18 power-packed presentations, this event brings together some of Australia’s most ambitious companies, each sitting at the cutting edge of their sectors and driving […]
EVE Health Group Commences Distribution of Dyspro Gummies to Treat Period Pain
EVE Health Group (ASX: EVE) has commenced dispatching its proprietary women’s health product Dyspro to distribution partners in preparation for an Australian launch. Dyspro is a first-in-class, cannabinoid-based gummy for the symptoms of dysmenorrhoea (painful menstruation) and endometriosis, two of the most prevalent and under-addressed conditions in women’s health. Following the completion of commercial-scale production, […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.